T1	Participants 1232 1335	Patients had to have histologically documented measurable breast cancer and a performance status of 0-1
T2	Participants 1337 1406	Patients could not have had prior chemotherapy for metastatic disease
T3	Participants 1408 1449	Prior adjuvant chemotherapy was permitted
T4	Participants 1451 1490	Patients could not have visceral crisis
